Answer extracted from the B2B Vault: The Biz To Biz Podcast — listen to the full episode below.
Can BCP157 and TB500 be legally sold right now?
From a legal standpoint, nothing has changed as of now. The FDA advisory committee signaled that peptides like BCP157 and TB500 might eventually have a legitimate compounding pathway, but rulemaking has not been finalized. Certification standards remain based on current applicable laws, not on future committee recommendations.
FDA signals interest, but law hasn't moved
The FDA's advisory committee meeting in April addressed the potential for peptide compounds to follow a legitimate compounding pathway in the future. However, signaling interest is different from finalizing rules. As Angela Salter explains in the episode, there are many regulatory steps between a committee's recommendation and actual rulemaking.
Certification bodies like LegitScript base their standards on laws and regulations that are currently in effect, not on what might become law in a year or two. This distinction matters for any merchant considering compounding or selling these peptides today.
The practical reality is that merchants cannot wait for future rules to materialize. They must operate within the legal framework as it exists now, which is why understanding current compliance requirements is critical for anyone in the telemedicine and pharmacy space.
"We certify based on current applicable laws and regulations, not what a committee thinks might be true in a year or two."
Angela Salter — Vice President of Enterprise Certification Sales and Partnerships at LegitScript. Angela oversees enterprise new customers and account management for certification customers, as well as relationships with strategic partners including ad platforms and card brands that require LegitScript certification for telemedicine and pharmacy businesses. She advises merchants weekly on compliance requirements for health care platforms.
For merchants, this means that certification standards have not shifted despite the FDA committee's discussion. Any peptide compound compounding or sales operation must still meet the same legal and regulatory review standards as before.
See also
Why do payment processors and advertising platforms require LegitScript certification?
These platforms require certification to align with their policies and reduce the risk of fake, dangerous, or misleading health care advertising, especially in high-risk categories like telemedicine and pharmacy.
What does LegitScript certification mean for a merchant operating in telemedicine and pharmacy?
Certification means a business has gone through a review process and demonstrated that its model, marketing, and offerings meet a defined set of legal and regulatory standards required by payment processors and ad platforms.
Key takeaways
- The FDA committee discussion does not represent a legal change—rulemaking requires multiple additional steps before any rules take effect.
- LegitScript and other certification bodies certify based on laws in force now, not anticipated future regulations.
- Merchants selling or compounding peptides like BCP157 and TB500 must comply with current regulations, regardless of future committee recommendations.
- Operating in telemedicine and pharmacy requires staying current with existing certification standards, which have not shifted since the FDA committee meeting.